In a recent decision, the Fourth Circuit considered a class action lawsuit brought by shareholders of a biopharma company, INC Research Holdings, Inc. (now Syneos Health Inc.). The shareholders had voted to approve a merger...more
1/9/2024
/ C-Suite Executives ,
Class Action ,
Control Person ,
Mergers ,
Securities Act of 1933 ,
Securities Exchange Act ,
Securities Fraud ,
Shareholder Approval ,
Shareholder Litigation ,
Shareholders ,
Stock Prices